Year |
Citation |
Score |
2020 |
Legendre M, Butt A, Borie R, Debray MP, Bouvry D, Filhol-Blin E, Desroziers T, Nau V, Copin B, Dastot-Le Moal F, Héry M, Duquesnoy P, Allou N, Bergeron A, Bermudez J, et al. Functional assessment and phenotypic heterogeneity of and mutations in interstitial lung diseases and lung cancer. The European Respiratory Journal. PMID 32855221 DOI: 10.1183/13993003.02806-2020 |
0.314 |
|
2020 |
Bondeelle L, Chevret S, Hurabielle C, Samy L, Goletto T, Costantini A, de Fontbrune FS, Michonneau D, Socié G, Tazi A, Bouaziz JD, Bergeron A. Effect of Ruxolitinib on lung function after allogeneic stem cell transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. PMID 32738501 DOI: 10.1016/J.Bbmt.2020.07.033 |
0.355 |
|
2020 |
Bondeelle L, Chevret S, Hurabielle C, Fontbrune FSD, Michonneau D, Tazi A, Bouaziz JD, Bergeron A. Effet du ruxolitinib sur la fonction respiratoire après allogreffe de cellules souches hématopoiétiques Revue Des Maladies Respiratoires ActualitéS. 12: 249. DOI: 10.1016/J.Rmra.2019.11.558 |
0.314 |
|
2019 |
Wilhelm B, Milan T, Celton M, Lagacé K, Roques E, Bresson E, Bergeron A, Hebert J, Lamontagne V, Cellot S, Barabé F. THE INTEGRATED USE OF HUMAN MODELS OF LEUKEMIA TO IDENTIFY POTENTIAL THERAPEUTIC TARGETS Experimental Hematology. 76: S92-S93. DOI: 10.1016/J.Exphem.2019.06.460 |
0.315 |
|
2018 |
Bondeelle L, Bergeron A. Managing pulmonary complications in allogeneic hematopoietic stem cell transplantation. Expert Review of Respiratory Medicine. PMID 30523731 DOI: 10.1080/17476348.2019.1557049 |
0.339 |
|
2018 |
Fertitta L, Sicre de Fontbrune F, Battistella M, De Masson A, Bergeron A, Ranta D, Vignon-Pennamen MD, Bagot M, Bouaziz JD. Folliculotropic Mycosis fungoides associated with GATA2 deficiency: a new skin manifestation. The British Journal of Dermatology. PMID 30101490 DOI: 10.1111/Bjd.17081 |
0.32 |
|
2018 |
Meignin V, Thivolet-Bejui F, Kambouchner M, Hussenet C, Bondeelle L, Mitchell A, Chagnon K, Begueret H, Segers V, Cottin V, Tazi A, Chevret S, Danel C, Bergeron A. Lung histopathology of noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation. Histopathology. PMID 29953629 DOI: 10.1111/His.13697 |
0.32 |
|
2018 |
Bergeron A, Chevret S, de Latour RP, Chagnon K, de Margerie-Mellon C, Rivière F, Robin M, Mani J, Lorillon G, Socié G, Tazi A. Noninfectious lung complications after allogeneic haematopoietic stem cell transplantation. The European Respiratory Journal. PMID 29650555 DOI: 10.1183/13993003.02617-2017 |
0.363 |
|
2018 |
Fertitta L, Fontbrune FSd, Battistella M, Masson AD, Bergeron A, Ranta D, Vignon-Pennamen M-, Bagot M, Bouaziz J-. Premier cas de mycosis fongoïde associé à un déficit en GATA2 Annales De Dermatologie Et De Venereologie. 145. DOI: 10.1016/J.Annder.2018.09.423 |
0.319 |
|
2017 |
Hilmi M, Bally C, Burns R, Lorillon G, Bergeron A, Fenaux P, Ades L. Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine. Annals of Hematology. PMID 29170809 DOI: 10.1007/S00277-017-3190-8 |
0.319 |
|
2017 |
Bergeron A, Cheng GS. Bronchiolitis Obliterans Syndrome and Other Late Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation. Clinics in Chest Medicine. 38: 607-621. PMID 29128013 DOI: 10.1016/J.Ccm.2017.07.003 |
0.362 |
|
2017 |
Brosseau S, Gounant V, Naltet C, Théou-Anton N, Cazes A, Smonig R, Neuville M, Khalil A, Mikail N, Meignin V, Bergeron A, Zalcman G. Lazarus Syndrome With Crizotinib in a Non-Small Cell Lung Cancer Patient With ROS1 Rearrangement and Disseminated Intravascular Coagulation. Clinical Lung Cancer. PMID 28844392 DOI: 10.1016/J.Cllc.2017.07.003 |
0.308 |
|
2017 |
Bergeron A, Chevret S, Granata A, Chevallier P, Vincent L, Huynh A, Tabrizi R, Labussiere-Wallet H, Bernard M, Chantepie S, Bay JO, Thiebaut-Bertrand A, Thepot S, Contentin N, Fornecker LM, et al. Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial. Jama. 318: 557-566. PMID 28787506 DOI: 10.1001/Jama.2017.9938 |
0.329 |
|
2017 |
Weatherald J, Chaumais MC, Savale L, Jaïs X, Seferian A, Canuet M, Bouvaist H, Magro P, Bergeron A, Guignabert C, Sitbon O, Simonneau G, Humbert M, Montani D. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study. The European Respiratory Journal. 50. PMID 28751413 DOI: 10.1183/13993003.00217-2017 |
0.301 |
|
2017 |
Bergeron A. Late-Onset Noninfectious Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation. Clinics in Chest Medicine. 38: 249-262. PMID 28477637 DOI: 10.1016/J.Ccm.2016.12.013 |
0.363 |
|
2017 |
Hurabielle C, Sicre de Fontbrune F, Moins-Teisserenc H, Robin M, Jachiet M, Coman T, Cassius C, Chasset F, de Masson A, Michonneau D, Bagot M, Bergeron A, Socié G, Peffault de Latour R, Bouaziz JD. Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic Graft-Versus-Host Disease. The British Journal of Dermatology. PMID 28422274 DOI: 10.1111/Bjd.15593 |
0.309 |
|
2017 |
Lothe-Cartier MN, Bellocq A, Latour RPD, Chevret S, Bergeron A. Allo’Rehab : profil fonctionnel à l’exercice, faisabilité et bénéfices de la réhabilitation respiratoire chez les patients atteints du syndrome de bronchiolite oblitérante postallogreffe de cellules souches hématopoïétiques Revue Des Maladies Respiratoires. 34. DOI: 10.1016/J.Rmr.2016.10.152 |
0.309 |
|
2017 |
Burbach M, Peraldi M, Bergeron A, Touratier S, Molina JM, Alanio A, Denis B, Bretagne S, Resche-Rigon M. Aspergillose invasive (IA) chez les patients transplantés rénaux : survie et étude monocentrique cas–témoins des facteurs de risque dans un service de transplantation rénale sur la période 2006–2016 Medecine Et Maladies Infectieuses. 47. DOI: 10.1016/J.Medmal.2017.03.196 |
0.307 |
|
2016 |
Lepelletier C, Bengoufa D, Lyes Z, de Masson A, Chasset F, Jachiet M, Michonneau D, Robin M, Peffault de Latour R, Sicre de Fontbrune F, Tandjaoui-Lambiotte Y, Bensussan A, Rybojad M, Tazi A, Bagot M, ... ... Bergeron A, et al. Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation. Jama Dermatology. PMID 27851860 DOI: 10.1001/Jamadermatol.2016.3976 |
0.317 |
|
2016 |
Barabé F, Gil L, Celton M, Bergeron A, Lamontagne V, Roques É, Lagacé K, Forest A, Johnson R, Pécheux L, Simard J, Pelloux J, Bellemare-Pelletier A, Gagnon E, Hebert J, et al. Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target. Leukemia. PMID 27780967 DOI: 10.1038/Leu.2016.302 |
0.309 |
|
2016 |
Chasset F, De Masson A, Le Buanec H, Xhaard A, Sicre de Fontbrune F, Robin M, Rybojad M, Parquet N, Brignier AC, Coman T, Bengoufa D, Bergeron A, Peffault de Latour R, Bagot M, Bensussan A, et al. APRIL levels are associated with disease activity in human chronic graft versus host disease. Haematologica. PMID 26992945 DOI: 10.3324/Haematol.2016.145409 |
0.312 |
|
2016 |
Burgel PR, Bergeron A, Knoop C, Dusser D. [Small airway diseases and immune deficiency]. Revue Des Maladies Respiratoires. PMID 26854188 DOI: 10.1016/J.Rmr.2015.11.003 |
0.313 |
|
2016 |
Bergeron A, Chevret S, Peffault De La Tour R, Chagnon K, De Bazelaire C, Rivière F, Robin M, Mani J, Lorillon G, Gérard S, Tazi A. Incidence, Risk Factors and Outcome of Late Onset Noninfectious Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation: A Prospective Cohort Study Blood. 128: 4562-4562. DOI: 10.1182/Blood.V128.22.4562.4562 |
0.343 |
|
2016 |
Cornetto MA, Chevret S, Abbes S, Mellon CDM, Hussenet C, Fontbrune FSD, Tazi A, Ribaud P, Bergeron A. Scanner thoracique précoce après allogreffe de cellules souches hématopoïétiques Revue Des Maladies Respiratoires. 33. DOI: 10.1016/J.Rmr.2015.10.671 |
0.306 |
|
2016 |
Haustraete E, Obert J, Diab S, Zini J, Hussenet C, Lerolle N, Tazi A, Bergeron A. Pneumopathies liées à l’idélalisib Revue Des Maladies Respiratoires. 33. DOI: 10.1016/J.Rmr.2015.10.225 |
0.312 |
|
2016 |
Lepelletier C, Bengoufa D, Lyes Z, Masson Ad, Chasset F, Tazi A, Bagot M, Socié G, Bergeron A, Bouaziz J. 273 Dermato-Pulmonary syndrome associated with anti-melanoma differentiation-associated gene 5 antibodies after allogeneic hematopoietic stem cell transplantation: a monocentric retrospective study Journal of Investigative Dermatology. 136. DOI: 10.1016/J.Jid.2016.06.293 |
0.317 |
|
2016 |
Lepelletier C, Bengoufa D, Lyes Z, Masson Ad, Chasset F, Jachiet M, Michonneau D, Robin M, Peffault-de-Latour R, Sicre-de-Fontbrune F, Tandjaoui-Lambiotte Y, Bensussan A, Rybojad M, Tazi A, Bagot M, ... ... Bergeron A, et al. Syndrome dermato-pulmonaire avec anticorps anti-MDA5 après allogreffe de cellules souches hématopoïétiques Annales De Dermatologie Et De Venereologie. 143. DOI: 10.1016/J.Annder.2016.09.175 |
0.325 |
|
2015 |
Hadjadj J, Malphettes M, Fieschi C, Oksenhendler E, Tazi A, Bergeron A. [Lung disease in adult common variable immunodeficiency]. Revue Des Maladies Respiratoires. PMID 26071128 DOI: 10.1016/J.Rmr.2015.05.005 |
0.321 |
|
2015 |
Bergeron A, Chevret S, Chagnon K, Godet C, Bergot E, Peffault de Latour R, Dominique S, de Revel T, Juvin K, Maillard N, Reman O, Contentin N, Robin M, Buzyn A, Socié G, et al. Budesonide/Formoterol for bronchiolitis obliterans after hematopoietic stem cell transplantation. American Journal of Respiratory and Critical Care Medicine. 191: 1242-9. PMID 25835160 DOI: 10.1164/Rccm.201410-1818Oc |
0.31 |
|
2015 |
Angileri F, Bergeron A, Morrow G, Lettre F, Gray G, Hutchin T, Ball S, Tanguay RM. Geographical and Ethnic Distribution of Mutations of the Fumarylacetoacetate Hydrolase Gene in Hereditary Tyrosinemia Type 1. Jimd Reports. 19: 43-58. PMID 25681080 DOI: 10.1007/8904_2014_363 |
0.689 |
|
2015 |
Barabe F, Celton M, Forest A, Bergeron A, Johnson R, Gil L, Bellemare-Pelletier A, Cellot S, Hebert J, Gagnon E, Wilhelm BT. Abstract A2-14: Integrated genetic and epigenetic analysis of model and patient acute myeloid leukemias Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A2-14 |
0.312 |
|
2014 |
Godet C, Le Goff J, Beby-Defaux A, Robin M, Raffoux E, Arnulf B, Roblot F, Frat JP, Maillard N, Tazi A, Bergeron A. Human metapneumovirus pneumonia in patients with hematological malignancies. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 61: 593-6. PMID 25440914 DOI: 10.1016/J.Jcv.2014.08.019 |
0.328 |
|
2014 |
Schlemmer F, Chevret S, Lorillon G, De Bazelaire C, Peffault de Latour R, Meignin V, Michallet M, Hermet E, Wyplosz B, Houdouin V, Marchand-Adam S, Socié G, Tazi A, Bergeron A. Late-onset noninfectious interstitial lung disease after allogeneic hematopoietic stem cell transplantation. Respiratory Medicine. 108: 1525-33. PMID 25260979 DOI: 10.1016/J.Rmed.2014.09.006 |
0.348 |
|
2014 |
Lerolle N, Raffoux E, Socie G, Touratier S, Sauvageon H, Porcher R, Bretagne S, Bergeron A, Azoulay E, Molina JM, Lafaurie M. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases. 20: O952-9. PMID 24861577 DOI: 10.1111/1469-0691.12688 |
0.338 |
|
2014 |
Wolfromm A, Porcher R, Legoff J, Peffault de Latour R, Xhaard A, de Fontbrune FS, Ribaud P, Bergeron A, Socié G, Robin M. Viral respiratory infections diagnosed by multiplex PCR after allogeneic hematopoietic stem cell transplantation: long-term incidence and outcome. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1238-41. PMID 24732781 DOI: 10.1016/J.Bbmt.2014.04.004 |
0.33 |
|
2013 |
Bergeron A, Godet C, Chevret S, Lorillon G, Peffault de Latour R, de Revel T, Robin M, Ribaud P, Socié G, Tazi A. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bone Marrow Transplantation. 48: 819-24. PMID 23208317 DOI: 10.1038/Bmt.2012.241 |
0.36 |
|
2012 |
Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Raffoux E, Vekhoff A, Cornet M, Isnard F, Brethon B, Lacroix C, Poirot JL, Bouges C, Derouin F, Tazi A, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 119: 1831-7; quiz 1956. PMID 22010103 DOI: 10.1182/Blood-2011-04-351601 |
0.354 |
|
2012 |
Schlemmer F, Lorillon G, Bergeron A. Non-infectious pulmonary complications after allogeneic hematopoietic stem cell transplantation | Les complications pulmonaires non infectieuses de l'allogreffe de cellules souches hématopoïétiques Reanimation. 21: S418-S425. DOI: 10.1007/S13546-011-0333-4 |
0.383 |
|
2011 |
Lorillon G, Robin M, Meignin V, Ribaud P, Lescoeur B, Gossot D, Socié G, Tazi A, Bergeron A. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation. The European Respiratory Journal. 38: 470-2. PMID 21804164 DOI: 10.1183/09031936.00003711 |
0.367 |
|
2011 |
Lamour C, Bergeron A. Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders. Revue Des Maladies Respiratoires. 28: e18-27. PMID 21742229 DOI: 10.1016/J.Rmr.2009.04.001 |
0.306 |
|
2011 |
Bergeron A, Bengoufa D, Feuillet S, Meignin V, Peffault de Latour R, Rybojad M, Gossot D, Azoulay E, Socié G, Tazi A. The spectrum of lung involvement in collagen vascular-like diseases following allogeneic hematopoietic stem cell transplantation: report of 6 cases and review of the literature. Medicine. 90: 146-57. PMID 21358437 DOI: 10.1097/Md.0B013E31821160Af |
0.331 |
|
2011 |
Borie R, Schneider S, Debray MP, Adle-Biasssette H, Danel C, Bergeron A, Mariette X, Aubier M, Papo T, Crestani B. Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome. Respiratory Medicine. 105: 130-6. PMID 21050739 DOI: 10.1016/J.Rmed.2010.07.017 |
0.325 |
|
2011 |
Wolfromm A, Porcher R, Legoff J, Latour RPd, Xhaard A, Ribaud P, Scieux C, Bergeron A, Socie G, Robin M. Viral Respiratory Infections After Allogeneic Hemaotpoietic Stem Cell Transplantation: Outcome and Prognosis Blood. 118: 491-491. DOI: 10.1182/Blood.V118.21.491.491 |
0.339 |
|
2010 |
Bergeron A, Porcher R, Sulahian A, de Bazelaire C, Chagnon K, Lacroix C, Raffoux E, Isnard F, Poirot J, Vekhoff A, Bouges-Michel C, Tazi A, Ribaud P. Mycological Diagnosis of Invasive Pulmonary Aspergillosis Should Depend on Both the Underlying Condition and the Neutropenia Status of Patients with Hematologic Malignancies Blood. 116: 1243-1243. DOI: 10.1182/Blood.V116.21.1243.1243 |
0.307 |
|
2009 |
Bergeron A, Chagnon K, Feuillet S, Chevret S, Tazi A. [Prospective evaluation of the efficacy of the combination of budesonide/formoterol in obstructive airway disease after allogeneic hematopoietic stem cell transplantation]. Revue Des Maladies Respiratoires. 26: 794-800. PMID 19953024 DOI: 10.1016/S0761-8425(09)72433-7 |
0.329 |
|
2009 |
Lamour C, Bergeron A. [Non-infectious pulmonary complications of myelodysplastic syndromes and chronic myeloproliferative disorders]. Revue Des Maladies Respiratoires. 26: 655-65. PMID 19623109 DOI: 10.1016/S0761-8425(09)74695-9 |
0.313 |
|
2009 |
Mourez T, Bergeron A, Ribaud P, Scieux C, de Latour RP, Tazi A, Socié G, Simon F, LeGoff J. Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerging Infectious Diseases. 15: 107-9. PMID 19116066 DOI: 10.3201/1501.080758 |
0.345 |
|
2008 |
Orejuela D, Jorquera R, Bergeron A, Finegold MJ, Tanguay RM. Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah-/- knockout mice model. Journal of Hepatology. 48: 308-17. PMID 18093685 DOI: 10.1016/J.Jhep.2007.09.014 |
0.513 |
|
2008 |
Langlois C, Jorquera R, Orejuela D, Bergeron A, Finegold MJ, Rhead WJ, Tanguay RM. Rescue from neonatal death in the murine model of hereditary tyrosinemia by glutathione monoethylester and vitamin C treatment Molecular Genetics and Metabolism. 93: 306-313. PMID 18023223 DOI: 10.1016/J.Ymgme.2007.09.018 |
0.506 |
|
2007 |
Madureira A, Bergeron A, Lacroix C, Robin M, Rocha V, de Latour RP, Ferry C, Devergie A, Lapalu J, Gluckmana E, Socié G, Ghannoum M, Ribaud P. Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. International Journal of Antimicrobial Agents. 30: 551-4. PMID 18029149 DOI: 10.1016/J.Ijantimicag.2007.07.026 |
0.334 |
|
2007 |
de Fontbrune FS, Robin M, Porcher R, Scieux C, de Latour RP, Ferry C, Rocha V, Boudjedir K, Devergie A, Bergeron A, Gluckman E, Azoulay E, Lapalu J, Socié G, Ribaud P. Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 1019-24. PMID 17879919 DOI: 10.1086/521912 |
0.324 |
|
2007 |
Robin M, Marque-Juillet S, Scieux C, Peffault de Latour R, Ferry C, Rocha V, Molina JM, Bergeron A, Devergie A, Gluckman E, Ribaud P, Socié G. Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome. Haematologica. 92: 1254-7. PMID 17666361 DOI: 10.3324/Haematol.11279 |
0.313 |
|
2007 |
Bergeron A, Réa D, Levy V, Picard C, Meignin V, Tamburini J, Bruzzoni-Giovanelli H, Calvo F, Tazi A, Rousselot P. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series. American Journal of Respiratory and Critical Care Medicine. 176: 814-8. PMID 17600277 DOI: 10.1164/Rccm.200705-715Cr |
0.317 |
|
2007 |
Bergeron A, Belle A, Chevret S, Ribaud P, Devergie A, Esperou H, Ades L, Gluckman E, Socié G, Tazi A. Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplantation. 39: 547-53. PMID 17351647 DOI: 10.1038/Sj.Bmt.1705637 |
0.371 |
|
2006 |
Bergeron A, Jorquera R, Orejuela D, Tanguay RM. Involvement of endoplasmic reticulum stress in hereditary tyrosinemia type I. The Journal of Biological Chemistry. 281: 5329-34. PMID 16317004 DOI: 10.1074/Jbc.M506804200 |
0.521 |
|
2005 |
Pavie J, Lacroix C, Hermoso DG, Robin M, Ferry C, Bergeron A, Feuilhade M, Dromer F, Gluckman E, Molina JM, Ribaud P. Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis. Journal of Clinical Microbiology. 43: 4902-4. PMID 16145172 DOI: 10.1128/Jcm.43.9.4902-4904.2005 |
0.309 |
|
2005 |
Dreumont N, Maresca A, Boisclair-Lachance JF, Bergeron A, Tanguay RM. A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay. Bmc Molecular Biology. 6: 1. PMID 15638932 DOI: 10.1186/1471-2199-6-1 |
0.473 |
|
2004 |
Bergeron A, Lettre F, Russo P, Morissette J, Tanguay RM. No evidence of maternal cell colonization in reverted liver nodules of tyrosinemia type I patients. Gastroenterology. 127: 1381-5. PMID 15521007 DOI: 10.1053/J.Gastro.2004.08.013 |
0.544 |
|
2003 |
Bergeron A, Jorquera R, Tanguay RM. [Hereditary tyrosinemia: an endoplasmic reticulum stress disorder?]. MéDecine Sciences : M/S. 19: 976-80. PMID 14613010 DOI: 10.1051/Medsci/20031910976 |
0.513 |
|
2001 |
Dreumont N, Poudrier JA, Bergeron A, Levy HL, Baklouti F, Tanguay RM. A missense mutation (Q279R) in the fumarylacetoacetate hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation. Bmc Genetics. 2: 9. PMID 11476670 DOI: 10.1186/1471-2156-2-9 |
0.517 |
|
2001 |
Bergeron A, D'Astous M, Timm DE, Tanguay RM. Structural and functional analysis of missense mutations in fumarylacetoacetate hydrolase, the gene deficient in hereditary tyrosinemia type 1. The Journal of Biological Chemistry. 276: 15225-31. PMID 11278491 DOI: 10.1074/jbc.M009341200 |
0.467 |
|
1998 |
Tazi A, Montcelly L, Bergeron A, Valeyre D, Battesti J, Hance AJ. Relapsing nodular lesions in the course of adult pulmonary Langerhans cell histiocytosis. American Journal of Respiratory and Critical Care Medicine. 157: 2007-2010. PMID 9620939 DOI: 10.1164/Ajrccm.157.6.9709026 |
0.314 |
|
Show low-probability matches. |